TP53 and cancer: Conversely, their absence does not exclude clinically relevant aggressive behaviour.[6] There is no clear relationship between immunohistochemical p53 overexpression and progression of PAs.[7,8] Abnormally, high levels of expression of p53, a tumour suppressor protein that in humans is encoded by the TP53 gene, are found in many cancers.